Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?
Buprenorphine diversion
Heroin
Non-pharmaceutical fentanyl
Unintentional drug overdose
Journal
The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759
Informations de publication
Date de publication:
17 Apr 2020
17 Apr 2020
Historique:
received:
11
09
2019
revised:
21
02
2020
accepted:
04
03
2020
pubmed:
21
4
2020
medline:
21
4
2020
entrez:
21
4
2020
Statut:
aheadofprint
Résumé
Unintentional drug overdoses have reached epidemic levels in the U.S. This study tests the hypothesis that people who have used non-prescribed buprenorphine more frequently in the past six months were less likely to experience a drug overdose during that same time period. Participants age 18 years or older with opioid use disorder who reported use of non-prescribed buprenorphine in the last six months were recruited from the Dayton, Ohio, area using a combination of targeted and modified respondent-driven sampling. Participants completed a structured interview, including six-month timeline follow-back, after informed consent. Logistic regression was used to test the association between (log-transformed) frequency of non-prescribed buprenorphine use and overdose in the previous six months, adjusted for confounding due to sex, homelessness, incarceration, substance use treatment, previous overdose, heroin/fentanyl injection, psychiatric comorbidity, and (log-transformed) frequencies of other (non-opioid) drug use. Almost 89% of 356 participants were white, 50.3% were male, and 78.1% had high school or greater education. Over 27% (n = 98) reported experiencing an overdose in the past six months. After adjusting for confounding, greater frequency of non-prescribed buprenorphine use was significantly associated with lower risk of overdose (AOR = 0.81, 95% CI = 0.66, 0.98; p = .0286). Experiencing an overdose more than six months ago (AOR = 2.19, 95% CI = 1.24, 3.97); injection as the most common route of administration of heroin/fentanyl (AOR = 2.49, 95% CI = 1.36, 4.71); and frequency of methamphetamine use (AOR = 1.13, 95% CI = 1.02, 1.27) were strongly associated with increased risk of recent overdose in multivariable analysis. The findings support our hypothesis that higher frequency of non-prescribed buprenorphine use is associated with lower risk of drug overdose, a potential harm reduction consequence of diversion. Improving the availability of buprenorphine though standard substance use disorder treatment, primary care, and other innovative methods is urgently needed.
Sections du résumé
BACKGROUND
BACKGROUND
Unintentional drug overdoses have reached epidemic levels in the U.S. This study tests the hypothesis that people who have used non-prescribed buprenorphine more frequently in the past six months were less likely to experience a drug overdose during that same time period.
METHODS
METHODS
Participants age 18 years or older with opioid use disorder who reported use of non-prescribed buprenorphine in the last six months were recruited from the Dayton, Ohio, area using a combination of targeted and modified respondent-driven sampling. Participants completed a structured interview, including six-month timeline follow-back, after informed consent. Logistic regression was used to test the association between (log-transformed) frequency of non-prescribed buprenorphine use and overdose in the previous six months, adjusted for confounding due to sex, homelessness, incarceration, substance use treatment, previous overdose, heroin/fentanyl injection, psychiatric comorbidity, and (log-transformed) frequencies of other (non-opioid) drug use.
RESULTS
RESULTS
Almost 89% of 356 participants were white, 50.3% were male, and 78.1% had high school or greater education. Over 27% (n = 98) reported experiencing an overdose in the past six months. After adjusting for confounding, greater frequency of non-prescribed buprenorphine use was significantly associated with lower risk of overdose (AOR = 0.81, 95% CI = 0.66, 0.98; p = .0286). Experiencing an overdose more than six months ago (AOR = 2.19, 95% CI = 1.24, 3.97); injection as the most common route of administration of heroin/fentanyl (AOR = 2.49, 95% CI = 1.36, 4.71); and frequency of methamphetamine use (AOR = 1.13, 95% CI = 1.02, 1.27) were strongly associated with increased risk of recent overdose in multivariable analysis.
DISCUSSION
CONCLUSIONS
The findings support our hypothesis that higher frequency of non-prescribed buprenorphine use is associated with lower risk of drug overdose, a potential harm reduction consequence of diversion. Improving the availability of buprenorphine though standard substance use disorder treatment, primary care, and other innovative methods is urgently needed.
Identifiants
pubmed: 32311513
pii: S0955-3959(20)30063-3
doi: 10.1016/j.drugpo.2020.102722
pmc: PMC9387534
mid: NIHMS1829346
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102722Subventions
Organisme : NIDA NIH HHS
ID : R01 DA040811
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no conflicts of interest.
Références
Addiction. 2002 Mar;97(3):319-27
pubmed: 11964108
Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S197-215
pubmed: 17109307
Int J Drug Policy. 2019 Dec;74:76-83
pubmed: 31563098
Ann Intern Med. 2018 Aug 7;169(3):137-145
pubmed: 29913516
Am Fam Physician. 2018 Mar 1;97(5):313-320
pubmed: 29671504
J Subst Abuse Treat. 2015 Oct;57:57-62
pubmed: 25980599
Harm Reduct J. 2013 Oct 16;10:24
pubmed: 24131626
Lancet. 2014 Jan 11;383(9912):124-5
pubmed: 24411967
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Drug Alcohol Depend. 2019 May 1;198:116-120
pubmed: 30909018
Science. 1984 Oct 5;226(4670):14-20
pubmed: 6474188
Drug Alcohol Depend. 2012 Dec 1;126(3):379-83
pubmed: 22704124
Int J Drug Policy. 2017 Aug;46:107-111
pubmed: 28735776
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
Int J Epidemiol. 2017 Jun 1;46(3):1077-1079
pubmed: 28402483
MMWR Morb Mortal Wkly Rep. 2012 Feb 17;61(6):101-5
pubmed: 22337174
Int J Drug Policy. 2015 Jan;26(1):51-8
pubmed: 25444768
Addiction. 1995 Nov;90(11):1497-502
pubmed: 8528035
Am J Addict. 2004;13 Suppl 1:S42-66
pubmed: 15204675
N Engl J Med. 2018 Jul 5;379(1):4-6
pubmed: 29972745
Drug Alcohol Depend. 2013 Jun 1;130(1-3):194-200
pubmed: 23219602
J Pain Palliat Care Pharmacother. 2006;20(2):5-13
pubmed: 16702131
Addict Behav. 2018 Nov;86:66-72
pubmed: 29198490
J Subst Abuse Treat. 2016 Nov;70:81-86
pubmed: 27692193
J Gen Intern Med. 2017 Jun;32(6):660-666
pubmed: 28194688
Drug Alcohol Depend. 1998 Aug 1;51(3):253-63; discussion 267-8
pubmed: 9787998
Drug Alcohol Depend. 1995 Nov;40(1):17-25
pubmed: 8746920
Drug Alcohol Depend. 2016 Dec 01;169:117-127
pubmed: 27810654
MMWR Morb Mortal Wkly Rep. 2016 Jan 01;64(50-51):1378-82
pubmed: 26720857
Drug Alcohol Depend. 2012 Feb 1;121(1-2):23-9
pubmed: 21885213
Drug Alcohol Depend. 2007 Jul 10;89(2-3):161-9
pubmed: 17280803
Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5
pubmed: 21862241
MMWR Morb Mortal Wkly Rep. 2019 Aug 30;68(34):737-744
pubmed: 31465320
Curr Drug Abuse Rev. 2011 Dec;4(4):292-7
pubmed: 21834754
Int J Drug Policy. 2008 Dec;19(6):450-8
pubmed: 18359216
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Addict Behav. 2012 Mar;37(3):225-33
pubmed: 22143002
J Addict Dis. 2012;31(1):3-7
pubmed: 22356664
Addiction. 2019 Sep;114(9):1602-1613
pubmed: 31166621
Trends Pharmacol Sci. 2005 Feb;26(2):82-7
pubmed: 15681025
Int J Drug Policy. 2010 May;21(3):215-21
pubmed: 19747812
J Subst Abuse Treat. 2019 Sep;104:148-157
pubmed: 31370979
JAMA. 2018 May 1;319(17):1819-1821
pubmed: 29715347
J Subst Abuse Treat. 2018 Sep;92:91-98
pubmed: 30032950
Drug Alcohol Depend. 2013 Feb 1;128(1-2):104-10
pubmed: 22974490
JAMA. 2015 Oct 13;314(14):1515-7
pubmed: 26462001
Drug Alcohol Rev. 1998 Jun;17(2):197-211
pubmed: 16203485
Drug Alcohol Depend. 2018 Dec 1;193:117-123
pubmed: 30359928
Int J Drug Policy. 2019 Sep;71:3-9
pubmed: 31146200
Curr Drug Abuse Rev. 2011 Mar;4(1):28-41
pubmed: 21466501
J Subst Abuse Treat. 2004 Jul;27(1):1-8
pubmed: 15223087
J Stud Alcohol. 2004 Nov;65(6):774-81
pubmed: 15700516
J Addict Med. 2017 Jul/Aug;11(4):280-285
pubmed: 28368905
Acad Emerg Med. 2007 Jul;14(7):616-23
pubmed: 17554010
Int J Drug Policy. 2019 Sep;71:118-124
pubmed: 31330267
Drug Alcohol Depend. 2019 Nov 1;204:107574
pubmed: 31568934
Drug Alcohol Depend. 2018 May 1;186:147-153
pubmed: 29573649
Drug Alcohol Depend. 2012 May 1;122(3):201-7
pubmed: 22036303
Addict Sci Clin Pract. 2019 May 6;14(1):20
pubmed: 31060600
N Engl J Med. 2007 Jan 11;356(2):157-65
pubmed: 17215533
Soc Sci Med. 2006 Aug;63(3):662-74
pubmed: 16597478
Drug Alcohol Depend. 2020 May 1;210:107958
pubmed: 32203863
N Engl J Med. 2019 Jan 3;380(1):71-79
pubmed: 30601750
J Addict Dis. 2013;32(1):53-67
pubmed: 23480248
J Subst Abuse Treat. 2017 Jul;78:43-47
pubmed: 28554602
Addiction. 2016 Apr;111(4):695-705
pubmed: 26599131
J Addict Med. 2014 Sep-Oct;8(5):315-26
pubmed: 25221984
Lancet. 2011 Apr 23;377(9775):1429-37
pubmed: 21497898
Br J Psychiatry. 1994 May;164(5):660-4
pubmed: 7921717
Addict Behav. 2012 Jun;37(6):691-6
pubmed: 22385733
J Adolesc Health. 2008 Mar;42(3):303-6
pubmed: 18295139
Drug Alcohol Depend. 2016 May 1;162:51-5
pubmed: 26993373
J Addict Med. 2017 Nov/Dec;11(6):420-426
pubmed: 28953504
Am J Addict. 2009 Sep-Oct;18(5):346-55
pubmed: 19874152
Subst Abus. 2020;41(1):110-120
pubmed: 31403914
Pain Med. 2015 Aug;16(8):1566-79
pubmed: 26077738
Int J Drug Policy. 2017 Aug;46:146-155
pubmed: 28735775
J Subst Abuse Treat. 2019 Aug;103:1-8
pubmed: 31229187
Science. 2018 Sep 21;361(6408):
pubmed: 30237320
Drug Alcohol Depend. 2005 Aug 1;79(2):167-79
pubmed: 16002026
Int J Drug Policy. 2013 Nov;24(6):e43-50
pubmed: 23199896
Drug Alcohol Depend. 2018 Sep 1;190:112-119
pubmed: 30005310
J Addict Med. 2011 Sep;5(3):175-80
pubmed: 21844833
Int J Drug Policy. 2018 Aug;58:64-70
pubmed: 29807248
J Subst Abuse Treat. 2005 Jun;28(4):321-9
pubmed: 15925266
BMC Psychiatry. 2019 May 15;19(1):150
pubmed: 31092225
BMJ. 2003 May 3;326(7396):959-60
pubmed: 12727768
Br J Addict. 1992 Mar;87(3):473-83
pubmed: 1559046
J Clin Psychopharmacol. 2011 Oct;31(5):678-80
pubmed: 21881461
Drug Alcohol Depend. 2006 Jul 27;83(3):193-8
pubmed: 16356659
J Subst Abuse Treat. 2005 Jun;28(4):341-9
pubmed: 15925268
Drug Alcohol Depend. 2019 Jul 1;200:34-39
pubmed: 31082666
Subst Abus. 2015;36(2):155-60
pubmed: 25837290
Am J Public Health. 2017 Jul;107(7):1092-1094
pubmed: 28520496
Int J Drug Policy. 2017 Aug;46:172-179
pubmed: 28687187
Addiction. 2003 Jun;98(6):739-47
pubmed: 12780362
Drug Alcohol Depend. 2005 Dec 12;80(3):297-302
pubmed: 15961257
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
Drug Alcohol Depend. 2013 Sep 1;132(1-2):387-90
pubmed: 23642316
J Subst Abuse Treat. 2018 Oct;93:19-25
pubmed: 30126537
J Consult Clin Psychol. 1994 Aug;62(4):843-50
pubmed: 7962889
Drug Alcohol Rev. 2009 Jul;28(4):347-52
pubmed: 19594787
Addiction. 2011 Jan;106(1):32-51
pubmed: 21054613
Compr Psychiatry. 1993 Nov-Dec;34(6):375-83
pubmed: 8131381
J Addict Med. 2018 Nov/Dec;12(6):459-465
pubmed: 30095563
Drug Alcohol Depend. 1999 Apr 1;54(2):155-61
pubmed: 10217555
Drug Alcohol Depend. 2019 Nov 1;204:107473
pubmed: 31520924
J Addict Dis. 2014;33(3):177-86
pubmed: 25115236
Natl Vital Stat Rep. 2016 Dec;65(10):1-15
pubmed: 27996932
MMWR Morb Mortal Wkly Rep. 2018 Jul 13;67(27):767-768
pubmed: 30001560